What's Happening at Biova

Biova® LLC

Biova, LLC Targets Joint Health and Skin Health Markets With BiovaFlex™ and BiovaDerm™ Water-Soluble Eggshell Membrane

Johnston, Iowa, USA; October 25, 2009—Biova, LLC, creators of patented OvaPure™ and Hydro5™ technology, and Ovacore™ water-soluble eggshell membrane, announce the introduction of two new all-natural ingredients for the human market: BiovaFlex™ for joint health, and BiovaDerm™ for skin health applications.

Biova, LLC partners with Valensa International for the development of joint health products featuring BiovaFlex™ water-soluble eggshell membrane.

Johnston, Iowa, USA; February 18, 2010—Biova, LLC, developers of patent-pending Hydro5™ technology and Ovacore™ natural water-soluble eggshell membrane, announce an agreement under which it will support Valensa International (Eustis, FL) in the development of joint health products with BiovaFlex™ natural eggshell membrane as a core active ingredient.

Johnston, Iowa, USA (February 28, 2013) — Biova® LLC, developer of patented Hydro5™ technology for water-soluble egg membrane, has increased the standardized protein profile of its BiovaFlex® ingredient to what it believes is a market-leading 88 percent.

“The science indicates bioactivity is tied to the natural, non-denatured egg membrane matrix,” said Matt Stegenga, Biova director of marketing. “The primary composition of this matrix is a natural ratio of complex proteins including glycosaminoglycans, collagen, elastin, desmosine, isodesmosine and transforming growth factor. So yes, hitting uniform 88 percent protein across all BiovaFlex production is significant for us because it’s important for our customers’ products.”

Page 4 of 6

  • Visit with Biova at: 

     

    March 10-12, 2017 :
    EXPO West/Engredea—Booth #566
    Anaheim Convention Center
    Anaheim, CA, USA

     

    May 9-11, 2017 : Vitafoods—Booth #D53
    Palexpo, Geneva, Switzerland